Algeria Commence Sinovac COVID-19 Vaccine Production

Algeria Commence Sinovac COVID-19 Vaccine Production (News Central TV )

Algeria has commenced the production of Covid-19 vaccine developed by Chinese firm Sinovac, with a target of about eight million doses monthly.

Prime Minister Aimene Benabderrahmane, while attending the launch of the production process at a factory in the eastern city of Constantine, called the effort a “big achievement”.

Algeria’s minister for the pharmaceutical industry, Lotfi Djamel Benbahmed

Algeria’s minister for the pharmaceutical industry, Lotfi Djamel Benbahmed said Algeria aims to achieve other projects of this kind and production could be doubled if needed.

He further stated that the country plans to export the vaccines as the firm making the jabs, was so far the only African company to be licenced to produce the jab.

Your Friends Also Read:  Hustler Literature Sheds Light on the World of Internet Fraud in Nigeria
Egypt’s Minister of Health and Population,Hala Zayed

Following a sharp spike in Covid-19 cases in past months, Algeria has seen a drop in recent weeks. In June, the WHO Strategic Advisory Group of Experts (SAGE) on Immunisation issued interim recommendations for the use of the Sinovac-CoronaVac vaccine against COVID-19.

Benbahmed had stated on National Radio Algeria in July that producing the vaccines locally will save Algeria $5 per dose and $250m when the North African nation has to produce 50 million doses of the vaccines.

Algeria had earlier this month announced a campaign to vaccinate about 70 percent of its 44 million population by the end of the year.

In a similar vein, Egypt will start producing the Chinese vaccine CoronaVac this week. The projected production of Sinovac in Algeria:

Your Friends Also Read:  Euro 2020: A European Championship of Africans

– 1 million doses in October 2021

– 2 million doses in November 2021

– 3 million doses in December 2021

– 5.3 million doses in January 2022

Annual production in 2022 is expected to exceed 65 million doses. The manufacturing of CoronaVac came following contracts signed last May between the two countries and the Chinese Sinopharm.

Leave your vote

All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from News Central TV.


Previous Article

World Heart Day 2021: Heart Diseases Claim 18.6m Lives Yearly

Next Article

Nigeria Needs to Address Incessant Strikes

Related Posts

Log In

Forgot password?

Forgot password?

Enter your account data and we will send you a link to reset your password.

Your password reset link appears to be invalid or expired.

Log in

Privacy Policy

Add to Collection

No Collections

Here you'll find all collections you've created before.